Page 99 - Genentech News Today

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Brian M. Culley, Lineage’s Chief...

/PRNewswire/ -- Baxter Planning, the leading provider of Service Parts Management technology, today announced that Roche Diagnostics Corporation, the North...

Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced the appointment of...

Eligible patients in the Marianas can now apply for free medication through Merck’s Patient Assistance Program, according to Delegate Gregorio Kilili C. Sablan (D-MP).

Confused about promotion opportunities after moving to industry? Here are some pointers. Confused about promotion opportunities after moving to industry? Here are some pointers.

BioNTech is initiating a Phase 1/2 clinical trial of the mRNA-based mpox vaccine program, BNT166The Coalition for Epidemic Preparedness Innovations (CEPI) commits funding of up to $90 million for the

BioNTech is initiating a Phase 1/2 clinical trial of the mRNA-based mpox vaccine program, BNT166The Coalition for Epidemic Preparedness Innovations (CEPI) commits funding of up to $90 million for the development of

Industry Veteran to lead Information Technology and CIO Community Engagement ...

Cryo-electron tomography is a hugely promising tool in visual proteomics — if researchers can work out what they are seeing. Cryo-electron tomography is a hugely promising tool in visual proteomics — if researchers can work out what they are seeing.

The high cost of developing drugs makes the use of artificial intelligence a natural fit for pharmaceutical companies.